Allodynia and hyperalgesia: review
The main purpose was to highlight the problem of hyperalgesia and allodynia. Main anatomic structures, which participate in nociception were mentioned in this article, with pathologic and pathophysiologic changes, that can be caused by hyperalgesia and allodynia. Main methods of diagnostics and assessment of mentioned symptoms were represented along with the modern approaches to treatment and prevention.
StéphaneLolignier, Niels Eijkelkamp, and John N. Wood. Mechanical allodynia // Pflugers Arch. 2015; 467: 133–139.
Jurgen Sandkuhler. Models and Mechanisms of Hyperalgesia and Allodynia // Physiolo. Rev. 2009; 89: 707–758.
Hardy JD, Wolff HG, Goodell H. Experimental evidence on the nature of cutaneous hyperalgesia. // J Clin Invest. 1950; 29: 115–140.
Richard A. Meyer, Matthias Ringkamp, James N. Campbell, and Srinivasa N. Raja. Neural Mechanisms of Hyperalgesia After Tissue Injury // JOHNS HOPKINS APL TECHNICAL DIGEST, VOLUME 26, NUMBER 1 (2005).
Ali, Z., Meyer, R. A., and Campbell, J. N., “Secondary Hyperalgesia to Mechanical but Not Heat Stimuli Following a Capsaicin Injection in Hairy Skin” // Pain 68; (2–3), 401–411 (1996).
Raja, S. N., Campbell, J. N., and Meyer, R. A., “Evidence for Different Mechanisms of Primary and Secondary Hyperalgesia Following Heat Injury to the Glabrous Skin” // Brain 107, 1179–1188 (1984).
Minami T, Okuda-Ashitaka E, Hori Y, Sakuma S, Sugimoto T, Sakimura K, Mishina M, Ito S.Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2 // Eur J Neurosci 11: 1849 –1856, 1999.
Kehl LJ, Trempe TM, Hargreaves KM. A new animal model for assessing mechanisms and management of muscle hyperalgesia // Pain 85: 333–343, 2000.
Tarpley JW, Kohler MG, Martin WJ. The behavioral and neuroanatomical effects of IB4-saporin treatment in rat models of nociceptive and neuropathic pain // Brain Res 1029: 65–76, 2004.
Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication // Ann NY Acad Sci 840: 289 –300, 1998.
Vera-Portocarrero LP, Zhang ET, King T, Ossipov MH, Vanderah TW, Lai J, Porreca F.Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways // Pain 129: 35– 45, 2007.
Sun S, Cao H, Han M, Li TT, Pan HL, Zhao ZQ, Zhang YQ. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis //Pain 129: 64 –75, 2007.
Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, Strichartz GR, Decosterd I, Ji RR. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance // J Neurosci 26: 3551–3560, 2006.
Saade NE, Baliki M, El-Khoury C, Hawwa N, Atweh SF, Apkarian AV, Jabbur SJ. The role of the dorsal columns in neuropathic behavior: evidence for plasticity and non-specificity // Neuroscience 115: 403– 413, 2002.
Palecek J, Paleckova V, Willis WD. The roles of pathways in the spinal cord lateral and dorsal funiculi in signaling nociceptive somatic and visceral stimuli in rats // Pain 96: 297–307, 2002.
Giller CA. The neurosurgical treatment of pain // Arch Neurol 60: 1537–1540, 2003.
Sanoja R, Vanegas H, Tortorici V. Critical role of the rostral ventromedial medulla in early spinal events leading to chronic constriction injury neuropathy in rats // J Pain. 9: 532–542, 2008.
Wei F, Dubner R, Ren K. Nucleus reticularis gigantocellularis and nucleus raphe magnus in the brain stem exert opposite effects on behavioral hyperalgesia and spinal Fos protein expression after peripheral inflammation // Pain. 80: 127–141, 1999.
Zhao P, Waxman SG, Hains BC. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21 // J Neurosci. 27:8893– 8902, 2007.
LaGraize SC, Labuda CJ, Rutledge MA, Jackson RL, Fuchs PN. Differential effect of anterior cingulate cortex lesion on mechanical hypersensitivity and escape/avoidance behavior in an animal model of neuropathic pain // Exp Neurol. 188: 139 –148, 2004.
Baliki M, Al-Amin HA, Atweh SF, Jaber M, Hawwa N, JabburSJ, Apkarian AV, Saade NE. Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbitofrontal area in the rat // Neuroscience. 120: 1093–1104, 2003.
Sekiguchi M, Kobayashi H, Sekiguchi Y, Konno SI, Kikuchi SI. Sympathectomy reduces mechanical allodynia, tumor necrosis factor-alpha expression, and dorsal root ganglion apoptosis following nerve root crush injury // Spine. 33: 1163–1169, 2008.
Hasudungan, A. (2013), ‘Nociceptors – an introduction to pain’ (Explains the ascending pathway, very easy to understand) // Youtube Video, (accessed 21.7.2015).
Marchand, S. (2008), ‘The physiology of pain mechanisms: From the periphery to the brain’ // Rheumatic Disease Clinics of North America. 34(2), 285–309.
Patel, N. B. (2010), ‘Physiology of pain’, Extracted from Kopf and Patel (Ed) “Guide to Pain Management in Low-Resource Settings”, 2010, International Association for the Study of Pain.
Paleckova V, Palecek J, McAdoo DJ, Willis WD. The non-NMDA antagonist CNQX prevents release of amino acids into the rat spinal cord dorsal horn evoked by sciatic nerve stimulation // Neurosci Lett. 148: 19 –22, 1992.
Lever IJ, Bradbury EJ, Cunningham JR, Adelson DW, Jones MG, McMahon SB, Marvizon JC, Malcangio M. Brain-derived neurotrophic factor is released in the dorsal horn by distinctive patterns of afferent fiber stimulation // J Neurosci. 21: 4469 – 4477, 2001.
Colvin LA, Duggan AW. Primary afferent-evoked release of immunoreactive galanin in the spinal cord of the neuropathic rat // Br J Anaesth. 81: 436 – 443, 1998.
Schaible HG, Freudenberger U, Neugebauer V, Stiller RU. Intraspinal release of immunoreactive calcitonin gene-related peptide during development of inflammation in the joint in vivo: a study with antibody microprobes in cat and rat // Neuroscience. 62: 1293–1305, 1994.
Dekin MS, Getting PA. In vitro characterization of neurons in the ventral part of the nucleus tractus solitarius. II. Ionic basis for repetitive firing pattern // J Neurophysiol. 58: 215–229, 1987.
Williams CA, Wu SY, Cook J, Dun NJ. Release of nociceptin-like substances from the rat spinal cord dorsal horn // Neurosci Lett. 244: 141–144, 1998.
Hutchison WD, Morton CR, Terenius L. Dynorphin A: in vivo release in the spinal cord of the cat // Brain Res. 532: 299–306, 1990.
Liang F, Jones EG. Peripheral nerve stimulation increases Fos immunoreactivity without affecting type II Ca2 /calmodulin dependent protein kinase, glutamic acid decarboxylase, or GABAA receptor gene expression in cat spinal cord // Exp Brain Res. 111: 326 –336, 1996.
Bullitt E, Lee CL, Light AR, Willcockson H. The effect of stimulus duration on noxious-stimulus induced c-fos expression in the rodent spinal cord // Brain Res. 580: 172–179, 1992.
Herdegen T, Kovary K, Leah J, Bravo R. Specific temporal and spatial distribution of JUN, FOS, and KROX-24 proteins in spinal neurons following noxious transsynaptic stimulation // J Comp Neurol. 313: 178 –191, 1991.
Wu J, Fang L, Lin Q, Willis WD. Fos expression is induced by increased nitric oxide release in rat spinal cord dorsal horn // Neuroscience. 96: 351–357, 2000.
Palecek J, Paleckova V, Willis WD.Fos expression in spinothalamic and postsynaptic dorsal column neurons following noxious visceral and cutaneous stimuli // Pain. 104: 249–257, 2003.
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw // JNeurosci. Methods. 53: 55–63, 1994.
Anseloni VC, Ennis M, Lidow MS. Optimization of the mechanical nociceptive threshold testing with the Randall-Selitto assay // J Neurosci Methods. 131: 93–97, 2003.
Christensen K, Jensen EM, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroids // Acta Chir Scand. 1982. 148(8): 653–5.
Braus DF, Krauss JK, Strobel J. The shoulder-hand syndrome after stroke: a prospective clinical trial // Ann Neurol. 1994 Nov. 36(5): 728–33.
Gobelet C, Waldburger M, Meier JL. The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy // Pain. 1992 Feb. 48(2): 171–5.
Adami S, Fossaluzza V, Gatti D, Fracassi E, Braga V. Bisphosphonate therapy of reflex sympathetic dystrophy syndrome // AnnRheumDis. 1997 Mar. 56(3): 201–4.
Varenna M, Zucchi F, Ghiringhelli D, Binelli L, Bevilacqua M, Bettica P. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study // J Rheumatol. 2000 Jun. 27(6): 1477–83.
Manicourt DH, Brasseur JP, Boutsen Y, Depreseux G, Devogelaer JP. Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity // Arthritis Rheum. 2004 Nov. 50(11): 3690–7.
Stengel M, Binder A, Baron R. Update on the diagnosis and management of complex regional pain syndrome // Adv Pain Manage. 2007. (3): 96–104.
Galer BS, Miller KV, Rowbotham MC. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury // Neurology. 1993 Jun. 43(6): 1233–5.
Glazer S, Portenoy RK. Systemic local anesthetics in pain control // J Pain Symptom Manage. 1991 Jan. 6(1): 30–9.
Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open label pilot study // Clin J Pain. 2000.
van Hilten BJ, van de Beek WJ, Hoff JI, Voormolen JH, Delhaas EM. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy // N Engl J Med. 2000 Aug 31. 343(9): 625–30.
Mellick GA, Mellicy LB, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy // J Pain Symptom Manage. 1995 May. 10(4): 265–6.
Serpell MG. Neuropathic Pain Study Group. Gabapentin in neuropathic pain sy // Pain. 2002. 99: 557–66.
van de Vusse AC, Goossens VJ, Kemler MA, Weber WE. Screening of patients with complex regional pain syndrome for antecedent infections. // Clin J Pain. 2001 Jun. 17(2): 110–4.
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial // JAMA. 1998 Dec 2. 280(21): 1837– 42.
This work is licensed under a Creative Commons Attribution 4.0 International License